Media Advisory
*For Planning Purposes Only*
Breakthrough T1D Chief Scientific Officer Dr. Sanjoy Dutta to Present at ISPAD on Global Type 1 Diabetes Screening
The October 19 session in Rotterdam, The Netherlands, will explore psychosocial impacts and benefits of support and monitoring in early stages of the disease
On October 19, Sanjoy Dutta, Ph.D., Chief Scientific Officer at Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, will present “A future now known: Creating space to prepare for T1D management,” during an industry symposium at the International Society for Pediatric and Adolescent Diabetes (ISPAD) annual conference in Rotterdam, The Netherlands. Following his presentation, Dr. Dutta will be joined in conversation by Dr. Kimber Simmons of the Barbara Davis Center for Diabetes and University of Colorado School of Medicine to discuss preparing for and potentially delaying a T1D diagnosis. The symposium will conclude with a full panel discussion, including Dr. Dutta and other presenters.
What: Breakthrough T1D Chief Scientific Officer presents at ISPAD symposium on global T1D screening and preparing for diagnosis, followed by a conversation and panel discussion
Who: Breakthrough T1D Chief Scientific Officer, Dr. Sanjoy Dutta, Dr. Kimber Simmons, Dr. Daniel Agardh, Dr. Thomas Danne
When: Thursday, October 19, 2023, symposium begins at 5:15 p.m. CEST, Dr. Dutta’s presentation begins at 6 p.m. CEST
Where: Session Hall 2, Willem Burger Zaal at the ISPAD Annual Conference, De Doelen, Schouwburgplein 50, 3012 CL Rotterdam, The Netherlands
###
